The Intellectual Property Advisory Committee (IPAC) helps the BIA shape the environment for IP ownership and protection. The committee includes technical experts and IP professionals from a range of member companies and experienced lawyers from the top private practice IP member firms.
- Brexit: advise the BIA on IP opportunities and challenges and participate in Government-industry workshops
- Unitary Patent and Unified Patent Court: track implementation of the UPC and input into Government planning for UK’s future involvement or exit
- US case law and patentable subject matter: monitor developments and provide comment where appropriate
- Nagoya Protocol and Access and Benefit Sharing: represent BIA members as guidance is developed and ensure BIA members are aware of how they might be impacted
- Maintain a watching brief on various issues, involving attendance at stakeholder meetings, including grace periods, Biotech Directive and Supplementary Protection Certificates (SPCs)
- Deliver IP Hot Topics session at the BIA UK Bioscience Forum
- Host summer drinks and Christmas lunch
Committee Chair: John Murphy, General Counsel and Company Secretary, Vectura
For more information contact Dr Martin Turner, Policy and Projects Manager
Allen & Overy LLP
Allen & Overy is an international legal practice with approximately 5,200 people working in 44 offices worldwide.
Apitope Technology Ltd
Apitope is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves’ disease, allergies and organ transplant rejection.
Astex Pharmaceuticals Ltd
Astex Pharmaceuticals is using an innovative, fragment-based drug discovery platform, Pyramid™, to identify and develop new medicines, primarily for the treatment of cancer.
Asymptote specialises in cryopreservation and liquid nitrogen-free freezers developed for GMP compliant cold chains for regenerative medicine and biobanking
Brunswick IP Limited
Brunswick IP provides pragmatic intellectual property advice to biotech, pharma & medtech businesses. We work closely with select clients, rolling-up our sleeves to provide a nimble, cost-effective IP service, focussed on commercial objectives, to best capture, protect & exploit intellectual property assets.
BTG is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders.
Cell and Gene Therapy Catapult
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation.
Circassia is a specialty biopharmaceutical company focused on developing world-class immunotherapies.
Consistently recognised as one of the leading life sciences firms worldwide, Covington is dedicated to serving the specialised needs of our life sciences clients in the UK, Europe, the United States, Asia and other major and emerging markets.
Field Fisher Waterhouse is a European law firm providing commercial solutions across a range of industry sectors. We have a particular focus on companies that are highly regulated and those with intellectual property and technology driven business models.
F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer.
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies is an industry-leading Biologics Contract Manufacturing Organisation with locations in Billingham, UK and Research Triangle Park, North Carolina, USA.
GSK is a global pharmaceutical company dedicated to helping people feel better, do more and live longer.
J A Kemp
J A Kemp & Co is the UK’s third largest firm of Patent and Trade Mark Attorneys, with over 40 qualified Attorneys and Solicitors, including more than 20 PhDs.
Kilburn & Strode LLP
Kilburn & Strode is a long established firm of patent and trade mark attorneys with a major bioscience practice.
Our strategy is to use our pioneering technology to grow our in-house drug discovery and development pipeline, as well as partner with others to maximise the technology's application in the development of novel medicines.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients.
Marks & Clerk Solicitors LLP
Marks & Clerk is one of the world’s leading IP firms. Its team of patent and trade mark attorneys is one of the largest in the UK, recognised alongside its team of lawyers as leaders in their field.
MedImmune is the worldwide biologics research and development arm of AstraZeneca with its headquarters in Gaithersburg, Maryland (US).
Mereo BioPharma Group Limited
Mereo is a UK-based biopharmaceutical company focused on the development of innovative medicines in rare and specialty areas.
Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A
We are proud of our heritage, but we're firmly focused on becoming the law firm of the future for our clients, and our people.
Powell Gilbert LLP
Powell Gilbert LLP is recognised as one of the UK's leading specialist Intellectual Property law practices.
Simmons & Simmons Service Company Ltd
Simmons & Simmons is recognised worldwide as a pre-eminent law firm for Life Sciences.
Slaughter and May
Slaughter and May is a major international law firm that advises in the following practice areas: general corporate and commercial, intellectual property, European Union (EU) and competition, litigation, pensions and employment, tax, environmental law, property and information technology.
Stratagem IPM Ltd
Stratagem Intellectual Property Management Ltd is a full-service, Cambridge UK-based, out sourced intellectual organisation and management company with global reach.
Vectura Group Plc
Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura’s main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25 billion.
Wilmer Cutler Pickering Hale and Dorr LLP
WilmerHale offers unparalleled legal representation across a comprehensive range of practice areas that are critical to the success of our clients.
Withers & Rogers LLP
At Withers & Rogers LLP our Life Sciences & Chemistry group is one of the largest in Europe with a depth of expertise and experience in the chemical, biochemical and pharmaceutical industries, as well as in academic research.
Abzena provides proprietary technologies and complementary services in the UK and US to enable the development and manufacture of biopharmaceuticals.
Lilly UK provides research and development, manufacturing and commercial operations on behalf of Eli Lilly & Company a major US pharmaceutical manufacturer. As one of the top UK pharmaceutical companies, we are dedicated to creating and delivering innovative pharmaceutical health care solutions that enable people to live longer, healthier and more active lives.
CMS Cameron McKenna Nabarro Olswang LLP